bpc-157 clinical trial nct02637284 A human was registered. The results were submitted. Then they disappeared from public view. In 2015, a Phase I, randomized, placebo-controlled trial (NCT02637284) was launched BPC-157 | Meridian Peptides
Description
Ethical approval This research was performed in accordance with the ethical standards of the institutional research committee and with the 1964 declaration and its later amendments
As a result, researchers can reuse a single vial multiple times while maintaining safety and effectiveness
Substantial sections of the rRNA have been replaced by additional protein sections (101105)
The proposed biology includes follicle signaling, reduced inflammation around follicles, and scalp conditions that make a growth phase easier to sustain
